Skip to main content
Download PDF

Correction: Plasma protein biomarkers reflective of the host response in patients developing Intensive Care Unit-acquired pneumonia

Critical Care volume 27, Article number: 420 (2023) Cite this article

The Original Article was published on 06 July 2023

Correction: Critical Care (2023) 27:269 https://doi.org/10.1186/s13054-023-04536-0

Following publication of the original article [1], the authors identified errors in the Additional file 1. A few of the supplementary figures were partially not visible.

The correct Additional file 1 file is included in this article.

Additional file 1 has been updated in this correction article and the original article [1] has been corrected.

Reference

  1. van Engelen TSR, Reijnders TDY, Paling FP, et al. Plasma protein biomarkers reflective of the host response in patients developing Intensive Care Unit-acquired pneumonia. Crit Care. 2023;27:269. https://doi.org/10.1186/s13054-023-04536-0.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Experimental and Molecular Medicine (CEMM), Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Room G2-105, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands

    Tjitske S. R. van Engelen, Tom D. Y. Reijnders, Hessel Peters-Sengers & Tom van der Poll

  2. Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands

    Fleur P. Paling & Marc J. M. Bonten

  3. Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium

    Leen Timbermont & Surbhi Malhotra-Kumar

  4. Department of Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands

    Jan A. J. W. Kluytmans

Authors
  1. Tjitske S. R. van Engelen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tom D. Y. Reijnders
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fleur P. Paling
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marc J. M. Bonten
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Leen Timbermont
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Surbhi Malhotra-Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jan A. J. W. Kluytmans
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hessel Peters-Sengers
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Tom van der Poll
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

for the ASPIRE-I. C. U. Study Team

  • Martin Wolkewitz
  • , Omar Ali
  • , Alexey Ruzin
  • , Leen Timbermont
  • , Christine Lammens
  • , Sebastiaan Hullegie
  • , Darren Troeman
  • , Denise van Hout
  • , Daniël Prins
  • , Rubana Kalyani
  • , Mark Eickhoff
  • , Kathryn Shoemaker
  • , Tuba Vilken
  • , Jelle Vlaeminck
  • , Jasmine Coppens
  • , Thomas van der Schalk
  • , Basil Britto Xavier
  • , Evelina Odisseeva
  • , Rossitza Vatcheva
  • , Michal Drab
  • , Jaromir Vajter
  • , Kadri Tamme
  • , Muriel Fartoukh
  • , Alain LePape
  • , Mickael Landais
  • , Gaetan Plantefève
  • , Evelina Tacconelli
  • , Achim Kaasch
  • , Róbert Jurkinya
  • , Iványi Zsolt
  • , Miranda van Rijen
  • , Olaf Cremer
  • , Biljana Carevic
  • , Jasna Jevdjić
  • , Dolores Escudero
  • , Miguel Sanchez Garcia
  • , Cristina Prat-Aymerich
  • , Borja Suberviola-Cañas
  • , Angel Arenzana-Seisdedos
  • , Hürrem Bodur
  • , Cenk Kirakli
  • , Ilkay Bozkurt
  •  & Sandra Long

Corresponding authors

Correspondence to Tjitske S. R. van Engelen or Tom van der Poll.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1

: STROBE statement; Supplementary methods: Definition of ICU-acquired pneumonia; Comorbidities; Causative pathogens; Sample collection; Assays; Statistical analysis; References; Supplementary tables: Table S1. Patient characteristics and clinical outcome of selected and not selected controls; Table S2. Missing clinical data; Table S3. Comorbidities; Table S4. Overview of linear mixed model estimates comparing cases with controls at baseline and onset of ICU-acquired pneumonia; Table S5. Patient characteristics and clinical outcome of cases in whom pneumonia occurred prior to day 7; Table S6. Patient characteristics of cases categorized into three groups according to the day of onset of ICU-acquired pneumonia; Supplementary figures: Fig. S1. Schematic representation of the clinical course of 277 cases during ICU-Stay; Fig. S2. Plasma protein biomarkers indicative of cytokine release and systemic inflammatory responses, and endothelial cell and procoagulant responses in Intensive Care Unit patients stratified according to the development of an ICU acquired Pneumonia or not at baseline and the time of the event. Fig. S3. Cytokine release and systemic inflammatory responses in ICU patients stratified according to the development of ICU-acquired pneumonia or not at baseline and event; Fig. S4. Endothelial cell and procoagulant responses in ICU patients stratified according to the development of ICU-acquired pneumonia or not at baseline and event; Fig. S5. Cytokine and systemic inflammatory responses in patients in whom pneumonia occurred prior to day 7; Fig. S6. Endothelial cell and procoagulant responses in Intensive Care Unit patients in whom pneumonia occurred prior to day 7; Fig. S7. Baseline cytokine release and systemic inflammatory responses in ICU patients who developed ICU acquired pneumonia; Fig. S8. Baseline endothelial cell and procoagulant responses in ICU patients who developed ICU-acquired pneumonia; ASPIRE-ICU Study Team.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

van Engelen, T.S.R., Reijnders, T.D.Y., Paling, F.P. et al. Correction: Plasma protein biomarkers reflective of the host response in patients developing Intensive Care Unit-acquired pneumonia. Crit Care 27, 420 (2023). https://doi.org/10.1186/s13054-023-04700-6

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13054-023-04700-6

Critical Care

ISSN: 1364-8535